BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 12629094)

  • 1. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
    van Pareren YK; de Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Stokvis-Brantsma WH; Rouwé CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1119-25. PubMed ID: 12629094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial.
    Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Massa GG; Rouwe CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4607-12. PubMed ID: 10599727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study.
    Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; van Leeuwen WJ; Asarfi A; van Rijn RR; Drop SL;
    Pediatr Res; 2001 Sep; 50(3):417-22. PubMed ID: 11518831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial.
    Blum WF; Ross JL; Zimmermann AG; Quigley CA; Child CJ; Kalifa G; Deal C; Drop SL; Rappold G; Cutler GB
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1383-92. PubMed ID: 23720786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Final height of growth hormone-treated GH-deficient children and girls with Turner's syndrome: the Dutch experience. The Dutch Advisory Group on Growth Hormone.
    de Muinck Keizer-Schrama S; Van den Broeck J; Sas T; Hokken-Koelega A
    Horm Res; 1999; 51 Suppl 3():127-31. PubMed ID: 10592457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height.
    Massa G; Heinrichs C; Verlinde S; Thomas M; Bourguignon JP; Craen M; François I; Du Caju M; Maes M; De Schepper J;
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4168-74. PubMed ID: 12970282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome.
    Rosenfield RL; Devine N; Hunold JJ; Mauras N; Moshang T; Root AW
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6424-30. PubMed ID: 16189255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome.
    Van Pareren YK; De Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Drop SL
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5442-8. PubMed ID: 12466334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial.
    Sas T; de Waal W; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3064-70. PubMed ID: 10487666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body proportions during long-term growth hormone treatment in girls with Turner syndrome participating in a randomized dose-response trial.
    Sas TC; Gerver WJ; de Bruin R; Stijnen T; de Muinck Keizer-Schrama SM; Cole TJ; van Teunenbroek A; Drop SL
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4622-8. PubMed ID: 10599729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of long-term growth hormone treatment on cardiac left ventricular dimensions and blood pressure in girls with Turner's syndrome. Dutch Working Group on Growth Hormone.
    Sas TC; Cromme-Dijkhuis AH; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; Drop SL
    J Pediatr; 1999 Oct; 135(4):470-6. PubMed ID: 10518081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrate metabolism during long-term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose-response study. Dutch Advisory Group on Growth Hormone.
    Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; Aanstoot HJ; Drop SL
    J Clin Endocrinol Metab; 2000 Feb; 85(2):769-75. PubMed ID: 10690889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final height in Turner syndrome patients treated with growth hormone.
    Pasquino AM; Passeri F; Municchi G; Segni M; Pucarelli I; Larizza D; Bossi G; Severi F; Galasso C
    Horm Res; 1996; 46(6):269-72. PubMed ID: 8982737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.
    Quigley CA; Crowe BJ; Anglin DG; Chipman JJ
    J Clin Endocrinol Metab; 2002 May; 87(5):2033-41. PubMed ID: 11994337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone treatment regimens in girls with Turner syndrome. Dutch Advisory Group on Growth Hormone.
    de Muinck Keizer-Schrama SM; Sas TC
    Acta Paediatr Suppl; 1999 Dec; 88(433):126-9. PubMed ID: 10626563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.